What longevity medicine actually is
The vocabulary of “longevity” has been claimed by an entire wellness industry that stretches across supplements, IV drips, branded protocols, and biohacking subcultures. Most of it is marketing. Some of it is genuinely interesting research delivered with too much certainty. A small subset is rigorous clinical practice grounded in measurable biomarkers and evidence-graded interventions.
Nuletic's framing of longevity is the third bucket. The aim is to extend healthspan — the years you spend with full cognitive, physical, and metabolic function — by addressing the upstream biological drivers of aging. That requires distinguishing well- supported interventions (hormone optimization where deficient, metabolic management, foundational lifestyle inputs) from promising-but-early ones (senolytics, NAD+ precursors, rapamycin, most peptides) and being honest about which is which.
Longevity work overlaps meaningfully with hormone optimization, peptide therapy, and metabolic health. None of these domains are independent. A serious longevity protocol pulls from all of them — which is why Nuletic is building an integrated platform rather than a series of single-condition services.
Core interventions
Below are the categories Nuletic covers in depth, organized around the biological mechanisms they address. Each section links to the full guide for that intervention.
Cellular & metabolic
The pathways that drive aging at the molecular level. NAD+ depletion, accumulating senescent cells, and dysfunctional autophagy are upstream of most age-related disease.
Restoring the coenzyme that powers mitochondrial function and DNA repair. What the protocols look like and where the evidence is strong vs. preliminary.
Compounds that selectively clear senescent cells. The science behind dasatinib + quercetin, fisetin, and the next-generation candidates in trials now.
Cellular cleanup that recycles damaged proteins and organelles. How fasting, exercise, and pharmacological mTOR inhibition trigger it.
The supplements with actual evidence vs. the supplements with marketing budgets. Ranked by mechanism, evidence quality, and cost-effectiveness.
Cognitive function
Protecting and enhancing brain function across decades. Cognitive decline is one of the most feared age-related changes — and increasingly addressable with combined interventions.
Recovery & resilience
How the body responds to stress and recovers. Hormesis — controlled stress that triggers adaptive responses — is the through-line for many longevity interventions.
What the research actually shows about cold exposure. Norepinephrine, brown fat activation, inflammation modulation, and where the evidence ends.
The medical, hormonal, and lifestyle causes of chronic fatigue. When it's worth getting bloodwork and what to test.
Hair as a downstream signal of hormonal, nutritional, and metabolic state. The treatments that work and the ones that don't.
Trending protocols
How to evaluate the headline-grabbing longevity protocols. Distinguishing actual signal from theatrical biohacking is harder than it should be.
What we're tracking
Longevity is one of the fastest-moving research areas in medicine. Several lines of work are likely to produce clinically actionable interventions over the next 2–5 years. Nuletic publishes new analysis as the evidence develops:
- Rapamycin and mTOR inhibition — moving from transplant medicine into intermittent low-dose longevity protocols with growing physician interest
- Senolytic combinations — beyond dasatinib + quercetin, the next generation of selective senescent-cell clearers is in early human trials
- Epigenetic age testing — methylation clocks becoming clinically actionable as repeated measurements show response to interventions
- Category 1 longevity peptides — Sermorelin, Tesamorelin, and others sitting at the intersection of legal compounding access and longevity-relevant mechanisms (see peptide therapy guide)
- GLP-1 longevity adjacency — accumulating cardiovascular, renal, and dementia-prevention signals from GLP-1 trials run for weight or diabetes endpoints
Related clusters
Longevity work is integrated by nature. The following Nuletic cluster hubs cover adjacent ground that becomes part of any complete longevity approach:
Peptide Therapy
Cognitive peptides (Semax, Cerebrolysin) and longevity-class compounds overlap meaningfully with longevity interventions. Several Category 1 peptides are part of well-rounded longevity protocols.
Hormone Optimization
Hormonal decline is one of the most measurable drivers of biological aging. Optimizing testosterone, estradiol, thyroid, and cortisol is foundational longevity work.
Weight Loss & GLP-1
Metabolic resilience is upstream of cardiovascular, cognitive, and inflammatory aging. GLP-1 medications are increasingly being studied for longevity-adjacent endpoints.
Medical disclaimer
This guide is for informational purposes only and has not been clinically reviewed. Longevity interventions vary widely in evidence quality. Always work with a licensed physician before starting any new therapy. Nuletic does not diagnose, treat, cure, or prevent any disease. Meet our medical team.